Pancreatic Cancer Research

ResearcherDalian Medical UniversityNo recent work listed

Zhaolin Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-0180-3286; OpenAlex author ID A5002725780. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. An oleanolic acid derivative, K73-03, inhibits pancreatic cancer cells proliferation in vitro and in vivo via blocking EGFR/Akt pathway. Co-author DOI 10.1002/cbin.11866↗
  2. Selaginellin B induces apoptosis and autophagy in pancreatic cancer cells via the JAK2/STAT3 signaling pathway. Last author PMID 33312355↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peng Chu · 2 shared papers, 2020–2022 · strength 0.26
  2. Zeyao Tang · 1 shared paper, 2022 · strength 0.16
  3. Na Li · 1 shared paper, 2022 · strength 0.16
  4. Zheng Zhou · 1 shared paper, 2022 · strength 0.16
  5. Xiaodong Ma · 1 shared paper, 2020 · strength 0.10
  6. Jinyong Peng · 1 shared paper, 2020 · strength 0.10
  7. Abdullah Shopit · 1 shared paper, 2020 · strength 0.10
  8. Zeyao Tang · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.